These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 17642228

  • 1. [Treatment guidelines for the use of biologics in rheumatoid arthritis; present and future].
    Miyasaka N, Koike R.
    Nihon Rinsho; 2007 Jul; 65(7):1169-78. PubMed ID: 17642228
    [Abstract] [Full Text] [Related]

  • 2. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
    Koike R, Takeuchi T, Eguchi K, Miyasaka N, Japan College of Rheumatology.
    Mod Rheumatol; 2007 Jul; 17(6):451-8. PubMed ID: 18084695
    [Abstract] [Full Text] [Related]

  • 3. Guidelines for the proper use of etanercept in Japan.
    Miyasaka N, Takeuchi T, Eguchi K.
    Mod Rheumatol; 2006 Jul; 16(2):63-7. PubMed ID: 16633923
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [TNF inhibitors for treatment of rheumatoid arthritis].
    Otomo K, Koike T.
    Nihon Naika Gakkai Zasshi; 2008 Oct 10; 97(10):2405-12. PubMed ID: 19149036
    [No Abstract] [Full Text] [Related]

  • 7. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
    Gaudin P.
    Rev Med Interne; 2008 Dec 10; 29(12):971-4. PubMed ID: 18571291
    [No Abstract] [Full Text] [Related]

  • 8. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S.
    Int J Rheum Dis; 2009 Jul 10; 12(2):118-24. PubMed ID: 20374328
    [Abstract] [Full Text] [Related]

  • 9. TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.
    Mikuls TR, Moreland LW.
    Expert Opin Pharmacother; 2001 Jan 10; 2(1):75-84. PubMed ID: 11336570
    [Abstract] [Full Text] [Related]

  • 10. [Etanercept--infliximab switch in rheumatoid arthritis 14 out of 131 patients treated with anti TNFalpha].
    Brocq O, Plubel Y, Breuil V, Grisot C, Flory P, Mousnier A, Euller-Ziegler L.
    Presse Med; 2002 Nov 23; 31(39 Pt 1):1836-9. PubMed ID: 12496713
    [Abstract] [Full Text] [Related]

  • 11. Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis.
    Laas K, Peltomaa R, Kautiainen H, Leirisalo-Repo M.
    Clin Rheumatol; 2008 Jul 23; 27(7):927-32. PubMed ID: 18414967
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.
    Hansen KE, Hildebrand JP, Genovese MC, Cush JJ, Patel S, Cooley DA, Cohen SB, Gangnon RE, Schiff MH.
    J Rheumatol; 2004 Jun 23; 31(6):1098-102. PubMed ID: 15170921
    [Abstract] [Full Text] [Related]

  • 13. The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
    Cohen G, Courvoisier N, Cohen JD, Zaltni S, Sany J, Combe B.
    Clin Exp Rheumatol; 2005 Jun 23; 23(6):795-800. PubMed ID: 16396697
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG, Arreghini M, Arnoldi C, Panni B, Marchesoni A, Tosi S, Pontikaki I.
    Arthritis Rheum; 2004 Apr 15; 51(2):301-2. PubMed ID: 15077278
    [No Abstract] [Full Text] [Related]

  • 16. Anti-tumor necrosis factor therapies.
    Taylor PC.
    Curr Opin Rheumatol; 2001 May 15; 13(3):164-9. PubMed ID: 11333343
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [TNFalpha inhibitors for the treatment of rheumatoid arthritis].
    Sany J, Kaiser MJ.
    Ann Med Interne (Paris); 2002 Feb 15; 153(1):34-40. PubMed ID: 11994688
    [Abstract] [Full Text] [Related]

  • 19. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A.
    JAMA; 2009 Feb 18; 301(7):737-44. PubMed ID: 19224750
    [Abstract] [Full Text] [Related]

  • 20. Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register.
    Simard JF, Neovius M, Askling J, ARTIS Study Group.
    Arthritis Rheum; 2012 Nov 18; 64(11):3502-10. PubMed ID: 22886739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.